PEAK6 Group’s Impax Laboratories, Inc. IPXL Stock Holding History

PEAK6 Group’s Portfolio IPXL Stock Details IPXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-10,000	Closed	-$203K	–	5208
2017 Q3	$203K	Buy	+10,000	New	+$191K	﹤0.01%	3279
2015 Q4	–	Sell	-87,700	Closed	-$3.09M	–	5652
2015 Q3	$3.09M	Buy	+87,700	New	+$3.95M	0.02%	1230
2015 Q2	–	Sell	-600	Closed	-$28K	–	5762
2015 Q1	$28K	Sell	600 -2,900	-83%	-$115K	﹤0.01%	4432
2014 Q4	$111K	Buy	+3,500	New	+$102K	﹤0.01%	3779
2014 Q1	–	Sell	-4,000	Closed	-$101K	–	5693
2013 Q4	$101K	Buy	+4,000	New	+$89.2K	﹤0.01%	4010

Other funds holding IPXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

PEAK6 Group's IPXL Position: Q4 2015 in Review

PEAK6 Group sold out of Impax Laboratories, Inc. (IPXL) in Q4 2015, closing a stake of 35,069 shares — an estimated $1.24M sold.

PEAK6 Group first reported a position in IPXL in Q3 2015 and held it in 1 quarter. The position peaked at $1.24M in Q3 2015. 196 funds tracked by Wall St. Rank hold IPXL as of Q4 2015.

PEAK6 Group reported no remaining Impax Laboratories, Inc. position as of Q4 2015 after selling out during the quarter.
PEAK6 Group sold 35,069 Impax Laboratories, Inc. shares in Q4 2015, an estimated $1.24M.
PEAK6 Group first reported a position in Impax Laboratories, Inc. in Q3 2015 and held it in 1 quarter.
PEAK6 Group's Impax Laboratories, Inc. position peaked at $1.24M in Q3 2015.
196 funds tracked by Wall St. Rank held Impax Laboratories, Inc. as of Q4 2015.

Based on PEAK6 Group's 13F filing for Q4 2015, filed 16 Feb 2016.